Treatment of Bronchitis with Fever
Antibiotics are generally not indicated for acute uncomplicated bronchitis, even with fever, unless pneumonia is suspected or the patient has specific risk factors. 1
Diagnosis and Assessment
Distinguish between acute bronchitis (typically viral) and pneumonia:
- Check for tachycardia (heart rate >100 beats/min), tachypnea (respiratory rate >24 breaths/min), fever >38°C, and abnormal chest examination findings (rales, egophony, tactile fremitus) 1
- If all these signs are absent in an immunocompetent adult <70 years, pneumonia is unlikely
- Colored sputum (green or yellow) does not indicate bacterial infection; it's due to inflammatory cells 1
Consider pertussis if cough persists >2 weeks with paroxysmal cough, whooping, or post-tussive emesis 2
Treatment Approach
First-line Treatment (Symptomatic Management)
For uncomplicated bronchitis with fever:
Antipyretics for fever management:
- Acetaminophen or NSAIDs like ibuprofen
Symptomatic relief options: 1, 3
- Cough suppressants (dextromethorphan, codeine)
- Expectorants (guaifenesin)
- First-generation antihistamines (diphenhydramine)
- Decongestants (phenylephrine)
- β-agonists (albuterol) - Note: Only beneficial in patients with underlying asthma or COPD 1
Adequate hydration and rest
When to Consider Antibiotics
Antibiotics should only be considered in specific circumstances:
- Suspected pneumonia based on clinical criteria 1
- Pertussis to reduce transmission 4
- High-risk patients (>65 years, immunocompromised) 4
- Exacerbation of chronic bronchitis meeting Anthonisen criteria (at least 2 of: increased dyspnea, increased sputum volume, increased sputum purulence) 3
If antibiotics are indicated for exacerbation of chronic bronchitis:
- First-line: Amoxicillin (3g/day) for 7-10 days 1, 3
- Alternatives for penicillin allergy: Macrolides or doxycycline 3
- For treatment failures: Amoxicillin-clavulanate, second/third-generation cephalosporins, or respiratory fluoroquinolones 3
Special Considerations for Chronic Bronchitis
For patients with established chronic bronchitis: 1
- Short-acting β-agonists should be used to control bronchospasm and may reduce chronic cough
- Ipratropium bromide improves cough
- Theophylline may be considered for chronic cough management (with careful monitoring)
Patient Education
- Emphasize that bronchitis is typically viral and self-limiting 3, 4
- Cough typically lasts 2-3 weeks regardless of treatment 3, 2
- Explain that antibiotics provide minimal benefit (reducing cough by only about half a day) and carry risks including allergic reactions, nausea, vomiting, and C. difficile infection 2
- Advise to return if symptoms persist beyond 3 weeks or if fever lasts >3-4 days 3
Common Pitfalls to Avoid
Overuse of antibiotics for viral bronchitis - more than 70% of acute bronchitis visits result in antibiotic prescriptions despite limited evidence of benefit 1
Misinterpreting colored sputum as indicating bacterial infection 1
Prolonged use of topical decongestants (>3 days) which can lead to rhinitis medicamentosa 3
Using β-agonists in patients without asthma or COPD, as they show no benefit in these populations 1
Missing pneumonia - always assess for signs of pneumonia requiring different management 1
Remember that acute bronchitis is self-limiting in most cases, and symptomatic treatment focusing on fever control and cough management is the mainstay of therapy.